AI Portfolio Summary
In 2025 Q4, Alphabet Inc. maintained a portfolio of 37 distinct positions. Conversely, Alphabet Inc. completely exited their position in ALECTOR INC.
Total Positions
37
Quarter
2025 Q4
Top Holding
ASTS (25.2%)
Top 10 Concentration
92.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-37 of 37
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ASTS
AST SPACEMOBILE...
|
Technology | 25.18% | 18.22% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
8,943,486 | $649,565,388 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PL
PLANET LABS PBC
|
Industrials | 24.42% | 17.21% |
#2
Prev: #2
|
6.5 | no change | no change |
P
S
|
31,942,641 | $629,908,881 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 10.33% | 8.01% |
#3
2
Prev: #5
|
5.5 | -788,175 | -19.1% |
P
S
|
3,345,102 | $266,437,374 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARM
ARM HOLDINGS PL...
|
Technology | 8.31% | 11.52% |
#4
1
Prev: #3
|
4.8 | no change | no change |
P
S
|
1,960,784 | $214,333,299 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FRSH
FRESHWORKS INC
|
Technology | 7.70% | 7.92% |
#5
1
Prev: #6
|
4.6 | no change | no change |
P
S
|
16,206,643 | $198,531,377 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PATH
UIPATH INC
|
Technology | 4.47% | 3.91% |
#6
3
Prev: #9
|
2.8 | no change | no change |
P
S
|
7,034,337 | $115,292,783 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GTLB
GITLAB INC
|
Technology | 3.96% | 5.10% |
#7
1
Prev: #8
|
2.6 | no change | no change |
P
S
|
2,724,712 | $102,258,441 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 3.55% | 5.20% |
#8
1
Prev: #7
|
2.4 | no change | no change |
P
S
|
1,551,102 | $91,592,573 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 2.67% | 2.90% |
#9
2
Prev: #11
|
2.1 | no change | no change |
P
S
|
1,036,937 | $68,821,509 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.23% | 2.60% |
#10
2
Prev: #12
|
0.9 | -1,023,888 | -42.4% |
P
S
|
1,388,583 | $57,528,994 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRME
PRIME MEDICINE ...
|
Healthcare | 2.23% | 3.81% |
#11
1
Prev: #10
|
1.9 | no change | no change |
P
S
|
16,562,498 | $57,471,868 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBOT
BRIDGEBIO ONCOL...
|
Healthcare | 1.37% | 1.36% |
#12
1
Prev: #13
|
1.5 | no change | no change |
P
S
|
2,823,126 | $35,345,538 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.51% | 0.34% |
#13
6
Prev: #19
|
1.2 | no change | no change |
P
S
|
1,568,753 | $13,271,651 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.47% | 0.29% |
#14
7
Prev: #21
|
1.2 | no change | no change |
P
S
|
241,264 | $12,217,609 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.45% | 0.45% |
#15
Prev: #15
|
0.2 | -719,067 | -49.1% |
P
S
|
744,948 | $11,680,785 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SANA
SANA BIOTECHNOL...
|
Healthcare | 0.44% | 0.41% |
#16
Prev: #16
|
1.2 | no change | no change |
P
S
|
2,812,500 | $11,446,875 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 0.35% | 0.20% |
#17
5
Prev: #22
|
1.1 | no change | no change |
P
S
|
293,256 | $9,026,420 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 0.35% | 0.32% |
#18
2
Prev: #20
|
1.1 | no change | no change |
P
S
|
321,604 | $8,914,863 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FIG
FIGMA INC
|
Technology | 0.31% | 0.46% |
#19
5
Prev: #14
|
1.1 | no change | no change |
P
S
|
215,582 | $8,056,299 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OSCR
OSCAR HEALTH IN...
|
Healthcare | 0.27% | 0.38% |
#20
3
Prev: #17
|
1.1 | no change | no change |
P
S
|
481,988 | $6,926,168 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WGS
GENEDX HOLDINGS...
|
Healthcare | 0.11% | 0.10% |
#21
3
Prev: #24
|
1.0 | no change | no change |
P
S
|
22,711 | $2,953,793 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 0.09% | 0.05% |
#22
9
Prev: #31
|
1.0 | no change | no change |
P
S
|
23,205 | $2,356,700 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 0.08% | 0.07% |
#23
5
Prev: #28
|
1.0 | no change | no change |
P
S
|
889,979 | $2,073,651 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 0.05% | 0.05% |
#24
8
Prev: #32
|
1.0 | no change | no change |
P
S
|
698,262 | $1,389,541 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HYPR
HYPERFINE INC
|
Healthcare | 0.03% | 0.05% |
#25
5
Prev: #30
|
1.0 | no change | no change |
P
S
|
898,720 | $880,746 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNYA
TENAYA THERAPEU...
|
Healthcare | 0.03% | 0.06% |
#26
3
Prev: #29
|
1.0 | no change | no change |
P
S
|
915,705 | $650,151 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QNCX
QUINCE THERAPEU...
|
Healthcare | 0.02% | 0.01% |
#27
8
Prev: #35
|
1.0 | no change | no change |
P
S
|
189,122 | $633,559 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.01% | 0.01% |
#28
8
Prev: #36
|
1.0 | no change | no change |
P
S
|
14,262 | $161,303 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.00% | 0.00% |
#29
8
Prev: #37
|
1.0 | no change | no change |
P
S
|
383 | $62,758 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #34) |
0.0 | -175,866 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GUTS
FRACTYL HEALTH ...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #33) |
0.0 | -662,584 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRNS
BARINTHUS BIOTH...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #27) |
0.0 | -1,513,644 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TCRX
TSCAN THERAPEUT...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #26) |
0.0 | -1,077,080 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #25) |
0.0 | -640,882 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FHTX
FOGHORN THERAPE...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #23) |
0.0 | -500,901 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #18) |
0.0 | -208,697 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MTSR
METSERA INC
|
Healthcare | 0.00% | 8.22% |
Sold All 😨
(Was: #4) |
0.0 | -3,783,528 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-37 of 37 holdings